Nek6 Inhibitors

NIMA-related kinases (NEKs) are a family of serine/threonine kinases that play key roles in various aspects of cell cycle regulation and cellular division processes. NEKs are involved in critical checkpoints and transitions during the cell cycle, particularly in mitosis and meiosis. They function by phosphorylating a range of substrates, thereby regulating processes such as centrosome separation, spindle assembly, and chromosome segregation. NEKs also respond to cellular stress and are involved in the DNA damage response pathway, ensuring genomic integrity. The dysregulation of NEK signaling is implicated in various diseases, including cancer, due to its role in controlling cell proliferation and division. Targeting NIMA-related kinases (NEKs) for disruption or inhibition is a significant area of interest, particularly in cancer research, due to their role in cell cycle regulation. Small molecule inhibitors have been developed to selectively target NEKs, aiming to disrupt their kinase activity and thus impede aberrant cell division. These inhibitors, by blocking NEK activity, can induce cell cycle arrest and lead to apoptosis in rapidly dividing cells. Such an approach is particularly relevant for cancer therapies, where the goal is to selectively target and inhibit the proliferation of cancerous cells.